Influenza vaccine response

1 paper1 finding

Human trial1

Interventions

1

Everolimus

upin humans1+20%

1 study

Everolimus improves influenza vaccine response in humans (about 20%).
Human trial
mTOR inhibition improves immune function in the elderly
Science translational medicine24 Dec 2014

More on Everolimus

Latest

1 in 12 months

Research Square4 Aug

LiteVax-adjuvanted influenza vaccine induces transient interferon-driven innate activation and accelerates early IgG3 responses in older adults

Preprint: non-randomised trial in 56 peopleInfluenza

Science Translational Medicine24 Dec

mTOR inhibition improves immune function in the elderly

Randomised trial in peoplemTOR inhibitors